Can cervical cancer be treated in the middle and late stages?

Mid- and late-stage cervical cancer is usually treatable, but the effectiveness of treatment is related to factors such as the stage of the disease and the patient’s physical condition. The main treatments for intermediate and advanced cervical cancer include radiotherapy, chemotherapy, targeted therapy, immunotherapy and palliative care. It is recommended that patients seek medical treatment promptly, and the doctor will develop an individualized treatment plan based on the specific situation.

Radiation therapy is one of the main treatments for advanced cervical cancer. It uses high-energy rays to kill cancer cells or prevent their growth. Radiation therapy can be divided into two forms: external irradiation and internal irradiation. External irradiation uses a machine outside the body to target the tumor area and internal irradiation puts the radioactive source directly into the body close to the tumor. Radiation therapy may cause side effects such as fatigue, skin reactions, and diarrhea, but these symptoms usually subside after treatment ends. For locally advanced cervical cancer, radiation therapy is often combined with chemotherapy to improve efficacy.

Chemotherapy uses anticancer drugs to kill cancer cells or prevent them from dividing. Commonly used chemotherapy drugs for intermediate and advanced cervical cancer include cisplatin injection, paclitaxel injection, and carboplatin injection. Chemotherapy can be used alone or simultaneously with radiation therapy. Chemotherapy drugs may cause adverse reactions such as nausea and vomiting, hair loss, bone marrow suppression, etc. Doctors will provide corresponding supportive treatment according to the patient's condition. Targeted therapy works on specific molecular targets of cancer cells. Commonly used targeted drugs, such as bevacizumab injection, can inhibit tumor angiogenesis and are often used in combination with chemotherapy.

Immunotherapy activates the patient's own immune system to fight cancer cells. Commonly used immune checkpoint inhibitors such as pembrolizumab injection are suitable for patients with recurrent or metastatic cervical cancer who express positive PD-L1 expression. Palliative care is mainly for patients who cannot be cured, aiming to relieve symptoms and improve quality of life, including pain management, psychological support and other measures. The treatment effect of intermediate and advanced cervical cancer varies from person to person. Some patients can achieve long-term survival through comprehensive treatment, while for some patients, controlling the progression of the disease and relieving symptoms are the main goals.

Patients with intermediate and advanced cervical cancer should pay attention to maintaining a balanced diet during treatment, appropriately supplementing high-quality protein such as fish, eggs, etc., and eating more fresh vegetables and fruits to obtain sufficient vitamins and dietary fiber. Appetite may decrease during treatment, and small meals may be taken. Maintaining moderate activity can help improve physical condition, but overexertion should be avoided. Regular review is crucial to monitor treatment effects and detect recurrence and metastasis in a timely manner. Patients should maintain a positive attitude and seek psychological counseling if necessary. Family members should provide adequate emotional support to help patients through the treatment period.